AFMD
Price
$0.81
Change
+$0.04 (+5.19%)
Updated
Apr 24, 02:10 PM (EDT)
Capitalization
12.11M
27 days until earnings call
GPCR
Price
$23.09
Change
-$0.24 (-1.03%)
Updated
Apr 24, 02:29 PM (EDT)
Capitalization
1.32B
14 days until earnings call
Ad is loading...

AFMD vs GPCR

Header iconAFMD vs GPCR Comparison
Open Charts AFMD vs GPCRBanner chart's image
Affimed
Price$0.81
Change+$0.04 (+5.19%)
Volume$754
Capitalization12.11M
Structure Therapeutics
Price$23.09
Change-$0.24 (-1.03%)
Volume$100
Capitalization1.32B
AFMD vs GPCR Comparison Chart
Loading...
AFMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AFMD vs. GPCR commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFMD is a Buy and GPCR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (AFMD: $0.77 vs. GPCR: $23.32)
Brand notoriety: AFMD and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AFMD: 96% vs. GPCR: 76%
Market capitalization -- AFMD: $12.11M vs. GPCR: $1.32B
AFMD [@Biotechnology] is valued at $12.11M. GPCR’s [@Biotechnology] market capitalization is $1.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AFMD’s FA Score shows that 0 FA rating(s) are green whileGPCR’s FA Score has 1 green FA rating(s).

  • AFMD’s FA Score: 0 green, 5 red.
  • GPCR’s FA Score: 1 green, 4 red.
According to our system of comparison, GPCR is a better buy in the long-term than AFMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AFMD’s TA Score shows that 6 TA indicator(s) are bullish while GPCR’s TA Score has 4 bullish TA indicator(s).

  • AFMD’s TA Score: 6 bullish, 2 bearish.
  • GPCR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AFMD is a better buy in the short-term than GPCR.

Price Growth

AFMD (@Biotechnology) experienced а +6.10% price change this week, while GPCR (@Biotechnology) price change was +25.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

AFMD is expected to report earnings on Aug 07, 2025.

GPCR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($1.32B) has a higher market cap than AFMD($12.1M). GPCR YTD gains are higher at: -14.012 vs. AFMD (-35.269). AFMD has higher annual earnings (EBITDA): -65.19M vs. GPCR (-157.24M). GPCR has more cash in the bank: 884M vs. AFMD (24.9M). GPCR has less debt than AFMD: GPCR (3.86M) vs AFMD (12.9M). AFMD has higher revenues than GPCR: AFMD (877K) vs GPCR (0).
AFMDGPCRAFMD / GPCR
Capitalization12.1M1.32B1%
EBITDA-65.19M-157.24M41%
Gain YTD-35.269-14.012252%
P/E RatioN/AN/A-
Revenue877K0-
Total Cash24.9M884M3%
Total Debt12.9M3.86M334%
FUNDAMENTALS RATINGS
AFMD: Fundamental Ratings
AFMD
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
4

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AFMDGPCR
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AFMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RDVIX5.300.07
+1.34%
Royce Dividend Value Invmt
PIIFX26.95N/A
N/A
Pioneer International Equity A
MGRTX42.71N/A
N/A
MFS International Growth R3
IRPSX10.35N/A
N/A
VY® T. Rowe Price Equity Income S
FSLZX40.52N/A
N/A
Fidelity Advisor Stock Selec Mid Cp Z

AFMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, AFMD has been loosely correlated with GPCR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AFMD jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AFMD
1D Price
Change %
AFMD100%
+4.24%
GPCR - AFMD
45%
Loosely correlated
+1.22%
BYSI - AFMD
40%
Loosely correlated
+10.29%
NTLA - AFMD
37%
Loosely correlated
-2.65%
LRMR - AFMD
35%
Loosely correlated
-5.04%
CRSP - AFMD
34%
Loosely correlated
-1.76%
More

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with AFMD. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then AFMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+1.22%
AFMD - GPCR
45%
Loosely correlated
+4.24%
DNLI - GPCR
43%
Loosely correlated
+1.85%
CKPT - GPCR
43%
Loosely correlated
N/A
VKTX - GPCR
42%
Loosely correlated
+1.22%
OLMA - GPCR
41%
Loosely correlated
+1.01%
More